Morgan Stanley (NYSE:MS) has begun coverage of Genmab (CSE:GMAB) (NASDAQ:GMAB) with an Equal-Weight rating and a price objective of $24, reduced slightly from the previous $25 target.

Investing.com -- Morgan Stanley (NYSE: MS) has named KKR & Co. Inc. (NYSE: KKR) its new top pick in the brokers, asset ...

Morgan Stanley (NYSE:MS – Get Free Report) announced that its Board of Directors has authorized a share buyback program on Tuesday, July 1st, RTT News reports. The company plans to buyback $20.00 ...

By taking the other route, and paying off your credit-card debt with $30,000 from your investments, you would forfeit around $6,700 over those three years, assuming a conservative 7% return or roughly ...

Morgan Stanley stock hit a new 52-week high, climbing to $142.63 on strong trading volume. The financial powerhouse reported ...

Morgan Stanley (MS) closed at $142.86 in the latest trading session, marking a +1.27% move from the prior day.

An announcement from JPMorgan Chase ( (JPM) ) is now available.

Mike Wilson, the chief stock strategist and CIO of Morgan Stanley, is optimistic about the stock market with an improvement ...

Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Morgan Stanley (MS) have what it takes? Let's find out.

Morgan Stanley (MS) is currently at $142.31, up $1.24 or 0.88% --Would be new all-time closing high (Based on available data back to Feb. 23, 1993) --Would be the first record close since Feb. 6, 2025 ...

Today, Zacks Equity Research discusses Morgan Stanley MS, The Goldman Sachs Group, Inc. GS and Robinhood Markets, Inc. HOOD ...

Wall Street’s largest lenders boosted their dividends after passing this year’s Federal Reserve stress tests, a hurdle that ...